0001127602-24-015076.txt : 20240513
0001127602-24-015076.hdr.sgml : 20240513
20240513160044
ACCESSION NUMBER: 0001127602-24-015076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240513
DATE AS OF CHANGE: 20240513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amouyal Philippe
CENTRAL INDEX KEY: 0001376854
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 24938839
MAIL ADDRESS:
STREET 1: C/O CAVA GROUP, INC.
STREET 2: 14 RIDGE SQUARE NW, SUITE 500
CITY: WASHINGTON
STATE: DC
ZIP: 20016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-13
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001376854
Amouyal Philippe
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
THE WOODLANDS
TX
77381
1
0
Stock Option (Right to Buy)
1.79
2024-05-13
4
A
0
44906
0
A
2034-05-13
Common Stock
44906
44906
D
Restricted Stock Units
0
2024-05-13
4
A
0
36810
0
A
Common Stock
36810
36810
D
Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.
Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
Each restricted stock unit represents a contingent right to receive one share of common stock.
/s/ Philippe J. Amouyal
2024-05-13